Loading organizations...
Key people at Sequoia Consulting Group, LLC.
Sequoia Consulting Group offers a platform and advisory services, optimizing people investment for investor-backed companies. It provides comprehensive solutions covering compensation, benefits, and risk management. Leveraging expert guidance and technology, the firm strategically manages client talent through data analytics for efficient acquisition and retention.
Founded around 2001 by CEO Greg Golub, Sequoia Consulting Group stemmed from the insight that high-growth, investor-backed enterprises need a unified talent strategy. Golub recognized the crucial need to optimize "people spend" to attract and retain talent, envisioning a firm blending expert advisory with powerful technology.
Sequoia primarily serves investor-backed businesses, including VC and private equity firms, and emerging small to medium-sized enterprises. Its vision empowers organizations to cultivate competitive employee experiences, fostering environments people excel. Focusing on holistic people investment strategies, the firm supports sustained business growth and workforce well-being.
Key people at Sequoia Consulting Group, LLC.
Sequoia Consulting Group, LLC is a San Diego, California-based life sciences consulting firm founded in 2013, specializing in technical, quality, scientific operations, business transformation, and program/project management for biotech, pharma, diagnostics, and medical device companies.[1] It supports clients across the full product lifecycle, from R&D to commercial operations, with highly experienced consultants who assist in executing objectives for early-stage and established firms.[1] The company was acquired by Hexagon Capital Alliance, a middle-market investment banking firm, enhancing its strategic positioning in the life sciences sector.[1]
Note: Multiple entities share similar names, including a larger HR/benefits firm (Sequoia at sequoia.com, founded ~2001, with 24+ years in total compensation, benefits, and risk management)[2][4][5] and an energy consulting group (since 1989, focused on supply chain and engineering).[3] This profile focuses on the life sciences LLC per the query's specificity.[1]
Sequoia Consulting Group, LLC was founded in 2013 by Brandy Bullen in San Diego, emerging from the incubator of its financial backer, Bootstrap Venture Partners.[1] Bullen leveraged her expertise to build a team of subject matter experts in life sciences, positioning the firm to go beyond advisory roles by aiding in project execution.[1] Early growth centered on serving blue-chip clients in biotech and pharma, with a focus on increasing successful outcomes through hands-on support.[1] The firm's acquisition by Hexagon Capital Alliance (formerly Moss Adams Capital, rebranded 2021) marked a pivotal evolution, integrating it into a network with 120+ years of middle-market experience across 300+ transactions in healthcare and related sectors.[1]
Sequoia rides the wave of booming life sciences innovation, fueled by advances in biotech, personalized medicine, and medtech amid post-pandemic R&D acceleration and regulatory pressures.[1] Its timing aligns with surging demand for specialized consulting as startups scale amid funding crunches and big pharma seeks agile partners for pipeline acceleration.[1] Market forces like talent shortages in quality/compliance and complex supply chains favor its execution-oriented model, while the Hexagon acquisition amplifies influence via deal-making networks in healthcare M&A.[1] In the tech-adjacent life sciences ecosystem, it influences by de-risking development, enabling faster market entry for diagnostics and devices that integrate AI/data analytics.
Sequoia Consulting Group, LLC is poised for expanded reach post-acquisition, likely targeting more M&A-driven growth in life sciences as biotech funding rebounds and global supply chains stabilize.[1] Trends like AI-enabled drug discovery, precision diagnostics, and regulatory harmonization will shape its trajectory, amplifying demand for its full-lifecycle expertise.[1] Its influence may evolve toward integrated advisory in consolidated markets, solidifying its niche as the execution partner that turns life sciences ambition into outcomes—echoing its founding promise of beyond-traditional impact.[1]
